CAMBRIDGE, Mass., July 28 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals
Incorporated (Nasdaq: VRTX) will webcast its corporate presentation at the
25th Annual Adams Harkness Summer Seminar in Boston. The presentation will be
delivered by John Alam, M.D., Vertex's Senior Vice President of Drug
Evaluation and Approval on Tuesday, August 2, 2005 at 2:00 p.m. EDT.
The presentation will be webcast live and may be accessed by visiting the
Vertex website at http://www.vrtx.com. A replay of the webcast will also be
available on the Company's website until August 16, 2005. To access the audio
webcast, go to Vertex's website and select '25th Annual Adams Harkness Summer
Seminar.' To ensure a timely connection to the webcast, it is recommended
that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes
the HIV protease inhibitor, Lexiva(R), with GlaxoSmithKline.
Lexiva(R) is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
Company News On-Call:
http://www.prnewswire.com/comp/938395.html
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
